| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.1M | +2694.2% |
| R&D Expense | $312K | -65.3% |
| SG&A Expense | $7.2M | -62.8% |
| Operating Income | -$7.8M | +65.0% |
| Interest Expense | $3.9M | +267.6% |
| Pre-tax Income | -$12.4M | +53.0% |
| Net Income | -$12.4M | +53.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68K | +79.7% |
| Accounts Receivable | $2.3M | — |
| Current Assets | $2.9M | +1136.6% |
| Total Assets | $41.7M | +5652.8% |
| Current Liabilities | $32.7M | +128.3% |
| Total Liabilities | $36.4M | +145.8% |
| Stockholders' Equity | $5.3M | +137.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.8M | +57.3% |
| Investing Cash Flow | $13K | — |
| Financing Cash Flow | $2.9M | +144.6% |